Angela Kashuba
Dean
John A. and Margaret P. McNeill, Sr. Distinguished Professor
Director, Clinical Pharmacology and Analytical Chemistry Core, UNC Center for AIDS Research
Adjunct Professor, Med-Infectious Diseases
(919) 966-1122
esop_dean@unc.edu
ADDRESS
100C Beard Hall, 301 Pharmacy Lane, CB# 7355, Chapel Hill, NC, 27599
DOWNLOAD CV
After obtaining her Bachelor of Science in pharmacy at the University of Toronto, Angela Kashuba, Pharm.D., completed a general practice residency at Women’s College Hospital, and practiced as a critical care pharmacist at Mount Sinai Hospital, in Toronto, Canada. Kashuba received her Pharm.D. from the State University of New York at Buffalo and completed postdoctoral pharmacology training at the Clinical Pharmacology Research Center at Bassett Healthcare in Cooperstown, New York.
Kashuba joined the UNC-Chapel Hill faculty in 1997. She was named the John and Deborah McNeill, Jr. Distinguished Professor in 2013 and served as chair of the Division of Pharmacotherapy and Experimental Therapeutics from 2015 to 2019, at which time she became Dean of the UNC Eshelman School of Pharmacy. She currently serves as Director of the UNC Center for AIDS Research Clinical Pharmacology and Analytical Chemistry Core.
Welcome to the UNC School of Pharmacy Clinical Pharmacology and Analytical Chemistry Laboratory web site! Our faculty and staff facilitate research in preclinical and clinical pharmacology and analytical chemistry in pursuit of a common goal: optimizing the prevention and treatment of HIV infection. We invite you to learn more about our vigorous research agenda. You are welcome to contact us for further information on our activities and services. We also encourage you to visit the UNC Center for AIDS Research website and our Clinical Pharmacology and Analytical Chemistry Core website.
- UNC Center for AIDS Research (P30, NIAID)
- The Multicenter AIDS Cohort Study(MACS)/Women’s Interagency HIV Study (WIHS) Combined Cohort Study (CCS) (U01, NIH)
- Single Dose Pharmacokinetics of Doravirine in HIV-infected Pregnant Women (Merck)
- Long-Acting Prevention Implantable System (LAPIS) (R01 Sub-award, NIH/RTI)
Angela Kashuba News